Inactive Instrument
Kadimastem Stock OTC Markets
Stocks
KMSTF
IL0011284614
Biotechnology & Medical Research
OTC Markets Traded
| Market Cap | 50.24M 43.3M 39.87M 37.43M 70.28M 4.75B 71.02M 471M 184M 2.33B 189M 185M 8.06B | P/E Ratio 2024 * |
-
| P/E Ratio 2025 | -2.81x |
|---|---|---|---|---|---|
| Enterprise Value | 48.39M 41.7M 38.4M 36.06M 67.7M 4.58B 68.41M 454M 177M 2.24B 182M 178M 7.76B | EV / Sales 2024 * |
-
| EV / Sales 2025 | - |
| Free-Float |
35.62% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.78% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.78% | +153.00% | - | - | 17.23M | |
| -0.12% | +1.04% | -13.08% | -12.43% | 43.58B | |
| -2.17% | +5.45% | +285.76% | +522.83% | 34.03B | |
| +0.44% | -2.46% | +14.20% | -17.35% | 29.77B | |
| -1.60% | -2.54% | -2.12% | +31.28% | 29.82B | |
| -0.29% | +9.47% | +13.95% | +21.93% | 25.42B | |
| +3.54% | +12.34% | - | - | 13.87B | |
| -1.26% | +0.81% | +54.77% | +109.24% | 13.35B | |
| -1.04% | -3.33% | +3.98% | +3.91% | 12.85B | |
| -1.18% | -0.61% | +105.37% | +75.32% | 12.22B | |
| Average | -0.56% | +2.03% | +57.85% | +91.84% | 23.88B | |
| Weighted average by Cap. | -0.73% | +2.02% | +59.38% | +102.72% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -26.55M -22.88M -21.07M -19.78M -37.14M -2.51B -37.54M -249M -97M -1.23B -99.65M -97.53M -4.26B | -8.3M -7.15M -6.59M -6.18M -11.61M -785M -11.73M -77.83M -30.32M -384M -31.15M -30.49M -1.33B |
| Net Debt | 7.35M 6.33M 5.83M 5.47M 10.28M 695M 10.39M 68.9M 26.84M 340M 27.57M 26.99M 1.18B | -1.85M -1.59M -1.46M -1.38M -2.58M -175M -2.61M -17.31M -6.74M -85.47M -6.93M -6.78M -296M |
Employees
11
